blood cancer

Omidubicel, a new cellular therapy, expands the availability of allogeneic (donor) stem cell transplants to more patients.

The Duke Med Alumni News Fall '22 Issue's cover story is "Researchers at Duke are Creating More Precise Approaches to Stopping Tumors."

Learn about new developments in next generation molecular sequencing tests at the DUHS Clinical Labs' Clinical Molecular Diagnostics Laboratory.

Leukemia survivor and Duke Heart NP Dayana Ramos will hold a Be The Match drive at Duke University Hospital on June 24

DCI member and physician-scientist Sandeep Dave, MD, MS, has been named the Wellcome Clinical Distinguished Professor of Medicine.

Team DCI met 118% of their fundraising goal of $5K in this year’s virtual Leukemia & Lymphoma Society Triangle Light the Night held Oct. 21.

Three years ago the retired NCCU Dean of Student Learning, 73, walked 60 miles to raise money for breast cancer. Now she's facing down an aggressive lymphoma.

Join Team DCI and "Light the Night" Oct. 21 to support blood cancer awareness and research. The virtual program includes a ceremony, lantern raising, social celebration & fireworks.

This OHE event, taped Aug. 19, focused on leukemia, lymphoma, and multiple myeloma: risk factors, symptoms, diagnosis,  latest treatments.

The new Duke Blood Cancer Center opens up the opportunity to transition some cancer treatments from the inpatient to the outpatient setting and the infusion room is open every day.

Research study participants encouraged Jessica Jin to pursue a career in nursing. After four years providing care to oncology patients at Duke, she’s won a national award.

DCI faculty Thomas Leblanc, MD, MA, MHS, FAAHPM, has been named a Fellow of the American Society of Clinical Oncology.

Ken Young, MD, PhD, will assume the role of chief, Hematopathology Division and DCI Blood Cancer Pathology Service, on Jan. 1, 2021.

In observance of Blood Cancer Awareness Month, Denise Spector, PhD, shares her husband's final months spent fighting cancer and thanks his heroes on 9100.

NCCN released new Guidelines for Patients in it's Immunotherapy Side Effects series, with the publication of a book focused on CAR T-Cell therapy.

The Duke Cancer Institute Virtual Grand Rounds Series, came to a successful summer close with its final session on June 19.

The LLS COVID-19 Patient Financial Aid Program will provide $250 to eligible blood cancer patients experiencing financial hardship due to the pandemic.

Medical oncologist Edwin P. Alyea, III, MD, formerly with Dana-Farber Cancer Institute, has been named chief medical officer (CMO) for Duke Cancer Institute.

David Bartlett, PhD, has been selected to receive an ASH Scholar Award to study impact of exercize training on CLL.

Harry Erba, MD, PhD, David Rizzieri, MD, and Thomas LeBlanc, MD, discuss the benefits of therapy for the great majority of older acute myeloid leukemia patients.

Hematologist-oncologist Suzanne Kirby, MD, PhD, will lead the way for Duke Cancer Institute’s Wake County teams as an honorary captain at Light the Night.

Duke Hematologic Malignancies & Cellular Therapy will host its second annual benefit Cornhole Games on Thursday, Oct. 3.

DCI blood cancer researchers shared new scientific discoveries and treatments in lymphomas, leukemias, and multiple myeloma at OncLive summit.

After college graduation, Shannon Voelkel started her “dream job” working for a well-known interior design firm. A year-and-a-half later, she learned life had other plans.